{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:15:15Z","timestamp":1768004115263,"version":"3.49.0"},"reference-count":70,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Atrial fibrillation (AF) is characterized by high morbidity and disability rate. The incidence of AF has rapidly increased due to increased aging population, causing a serious burden on society and patients. Therefore, it is necessary to determine the prevention and treatment of AF. Several studies have assessed the occurrence, development mechanism, and intervention measures of AF. The human gut has several non-pathogenic microorganisms forming the gut flora. The human gut microbiota plays a crucial role in the construction and operation of the metabolic system and immune system. Emerging clinical studies and basic experiments have confirmed that intestinal flora and its metabolites have a role in some metabolic disorders and chronic inflammatory diseases. Moreover, the gut microbiota has a role in cardiovascular diseases, such as hypertension and heart failure. However, the relationship between AF and gut microbiota is unclear. This review summarizes the relevant literature on the relationship between AF and intestinal flora with its metabolites, including Trimethylamine N-Oxide, short-chain fatty acids, lipopolysaccharide and bile acids. Therefore, this review may enhance further development of related research.<\/jats:p>","DOI":"10.3389\/fcvm.2022.948755","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T05:54:00Z","timestamp":1656654840000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["The Relationship Between Atrial Fibrillation and Intestinal Flora With Its Metabolites"],"prefix":"10.3389","volume":"9","author":[{"given":"Dasheng","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyue","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2333721419859687","article-title":"Prevalence and incidence of atrial fibrillation and other arrhythmias in the general older population: findings from the swedish national study on aging and care","volume":"5","author":"Lindberg","year":"2019","journal-title":"Gerontol Geriatr Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1093\/eurheartj\/ehv513","article-title":"Atrial fibrillation in heart failure: what should we do?","volume":"36","author":"Kotecha","year":"2015","journal-title":"Eur Heart J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1161\/CIRCULATIONAHA.119.041303","article-title":"Stroke risk as a function of atrial fibrillation duration and CHA2DS2-VASc score","volume":"140","author":"Kaplan","year":"2019","journal-title":"Circulation."},{"key":"B4","doi-asserted-by":"publisher","first-page":"682721","DOI":"10.3389\/fmicb.2021.682721","article-title":"A metagenome-wide association study of the gut microbiome and metabolic syndrome","volume":"12","author":"Qin","year":"2021","journal-title":"Front Microbiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3389\/fmicb.2020.01065","article-title":"The relationship between gut microbiota and inflammatory diseases: the role of macrophages","volume":"11","author":"Wang","year":"2020","journal-title":"Front Microbiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"4439","DOI":"10.1111\/bph.14483","article-title":"Contribution of the commensal microbiota to atherosclerosis and arterial thrombosis","volume":"175","author":"Kiouptsi","year":"2018","journal-title":"Br J Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40168-016-0222-x","article-title":"Gut microbiota dysbiosis contributes to the development of hypertension","volume":"5","author":"Li","year":"2017","journal-title":"Microbiome."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1161\/HYPERTENSIONAHA.115.05315","article-title":"Gut dysbiosis is linked to hypertension","volume":"65","author":"Yang","year":"2015","journal-title":"Hypertension."},{"key":"B9","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1161\/HYPERTENSIONAHA.115.06672","article-title":"Role of the gut microbiome in obstructive sleep apnea\u2013induced hypertension","volume":"67","author":"Durgan","year":"2016","journal-title":"Hypertension."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.cjca.2014.09.010","article-title":"Trimethylamine-N-oxide: a carnitine-derived metabolite that prolongs the hypertensive effect of angiotensin II in rats","volume":"30","author":"Ufnal","year":"2014","journal-title":"Can J Cardiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.yjmcc.2019.07.004","article-title":"Gut microbe-derived metabolite trimethylamine N-oxide accelerates fibroblast-myofibroblast differentiation and induces cardiac fibrosis","volume":"134","author":"Yang","year":"2019","journal-title":"J Mol Cell Cardiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e002314","DOI":"10.1161\/CIRCHEARTFAILURE.115.002314","article-title":"Choline diet and its gut microbe-derived metabolite, trimethylamine N-Oxide, exacerbate pressure overload-induced heart failure","volume":"9","author":"Organ","year":"2016","journal-title":"Circ Heart Failure."},{"key":"B13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1017\/S0029665120006916","article-title":"SCFA mechanisms and functional importance in the gut","volume":"80","author":"Martin-Gallausiaux","year":"2021","journal-title":"Proc Nutr Soc."},{"key":"B14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","article-title":"Bile acid metabolites control TH17 and Treg cell differentiation","volume":"576","author":"Hang","year":"2019","journal-title":"Nature."},{"key":"B15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","article-title":"Bile acid\u2013microbiota crosstalk in gastrointestinal inflammation and carcinogenesis","volume":"15","author":"Jia","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"6242","DOI":"10.3390\/ijms22126242","article-title":"Interaction between lipopolysaccharide and gut microbiota in inflammatory bowel diseases","volume":"22","author":"Candelli","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.3892\/etm.2019.7943","article-title":"Dysbiosis of Gram-negative gut microbiota and the associated serum lipopolysaccharide exacerbates inflammation in type 2 diabetic patients with chronic kidney disease","volume":"18","author":"Salguero","year":"2019","journal-title":"Exp Therap Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"giz058","DOI":"10.1093\/gigascience\/giz058","article-title":"Disordered gut microbiota and alterations in metabolic patterns are associated with atrial fibrillation","volume":"8","author":"Zuo","year":"2019","journal-title":"GigaScience"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e00422","DOI":"10.1128\/mSystems.00422-19","article-title":"Duration of persistent atrial fibrillation is associated with alterations in human gut microbiota and metabolic phenotypes","volume":"4","author":"Zuo","year":"2019","journal-title":"mSystems."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e00071","DOI":"10.1128\/mSphere.00071-20","article-title":"Different types of atrial fibrillation share patterns of gut microbiota dysbiosis","volume":"5","author":"Zuo","year":"2020","journal-title":"mSphere"},{"key":"B21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00380-020-01669-y","article-title":"Gut microbial composition in patients with atrial fibrillation: effects of diet and drugs","volume":"36","author":"Tabata","year":"2021","journal-title":"Heart Vessels."},{"key":"B22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.schres.2018.09.014","article-title":"Differences in gut microbiome composition between persons with chronic schizophrenia and healthy comparison subjects","volume":"204","author":"Nguyen","year":"2019","journal-title":"Schizophr Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"14405","DOI":"10.1038\/srep14405","article-title":"Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci Rep."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e01077","DOI":"10.1128\/spectrum.01077-21","article-title":"Gut microbiota and metabolites in atrial fibrillation patients and their changes after catheter ablation","volume":"10","author":"Huang","year":"2022","journal-title":"Microbiol Spect"},{"key":"B25","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1099\/ijsem.0.000788","article-title":"Reclassification of Eubacterium rectale (Hauduroy et al. 1937) Pr\u00e9vot 1938 in a new genus Agathobacter gen. nov. as Agathobacter rectalis comb. nov., and description of Agathobacter ruminis sp. nov., isolated from the rumen contents of sheep and cows","volume":"66","author":"Rosero J","year":"2016","journal-title":"Int J Syst Evol Microbiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e00051","DOI":"10.1128\/mSystems.00051-17","article-title":"Insights into butyrate production in a controlled fermentation system via gene predictions","volume":"2","author":"Esquivel-Elizondo","year":"2017","journal-title":"mSystems."},{"key":"B27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40168-020-00821-0","article-title":"Gut microbiota and cardiovascular disease: opportunities and challenges","volume":"8","author":"Kazemian","year":"2020","journal-title":"Microbiome."},{"key":"B28","doi-asserted-by":"publisher","first-page":"12672","DOI":"10.1073\/pnas.1904099116","article-title":"Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn's disease, produces an inflammatory polysaccharide","volume":"116","author":"Henke","year":"2019","journal-title":"Proc Nat Acad Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s40168-020-00923-9","article-title":"The interplay between host genetics and the gut microbiome reveals common and distinct microbiome features for complex human diseases","volume":"8","author":"Xu","year":"2020","journal-title":"Microbiome."},{"key":"B30","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1161\/01.CIR.0000112575.66565.84","article-title":"Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice","volume":"109","author":"Oyama","year":"2004","journal-title":"Circulation."},{"key":"B31","doi-asserted-by":"publisher","first-page":"10679","DOI":"10.1073\/pnas.0403249101","article-title":"Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E","volume":"101","author":"Michelsen","year":"2004","journal-title":"Proc Nat Acad Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1842990","article-title":"Phlorizin ameliorates obesity-associated endotoxemia and insulin resistance in high-fat diet-fed mice by targeting the gut microbiota and intestinal barrier integrity","volume":"12","author":"Zhang","year":"2020","journal-title":"Gut Microbes."},{"key":"B33","doi-asserted-by":"publisher","first-page":"4999","DOI":"10.4049\/jimmunol.1402598","article-title":"Lipopolysaccharide Regulation of Intestinal Tight Junction Permeability Is Mediated by TLR4 Signal Transduction Pathway Activation of FAK and MyD88","volume":"195","author":"Guo","year":"2015","journal-title":"J Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/cmi.2015.09","article-title":"Colonization of germ-free mice with a mixture of three lactobacillus strains enhances the integrity of gut mucosa and ameliorates allergic sensitization","volume":"13","author":"Kozakova","year":"2016","journal-title":"Cell Mol Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1177\/0148607113486809","article-title":"Lactobacillus GG and tributyrin supplementation reduce antibiotic-induced intestinal injury","volume":"37","author":"Cresci","year":"2013","journal-title":"J Parenter Enteral Nutr."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e005784","DOI":"10.1161\/JAHA.117.005784","article-title":"Gut-derived serum lipopolysaccharide is associated with enhanced risk of major adverse cardiovascular events in atrial fibrillation: Effect of adherence to mediterranean diet","volume":"6","author":"Pastori","year":"2017","journal-title":"J Am Heart Assoc."},{"key":"B37","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/cvr\/cvab114","article-title":"Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome","volume":"118","author":"Zhang","year":"2022","journal-title":"Cardiovasc Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3760\/cma.j.cn112148-20210106-00015","article-title":"Metagenomic data-analysis reveals enrichment of lipopolysaccharide synthesis in the gut microbiota of atrial fibrillation patients","volume":"50","author":"Zuo","year":"2022","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-018-0451-2","article-title":"The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer's disease","volume":"10","author":"Vogt","year":"2018","journal-title":"Alzheimer Res Ther."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-01387-y","article-title":"Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients","volume":"7","author":"Xu","year":"2017","journal-title":"Sci Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"151","DOI":"10.5853\/jos.2019.00472","article-title":"Gut microbiota and ischemic stroke: the role of trimethylamine N-oxide","volume":"21","author":"Nam","year":"2019","journal-title":"J Stroke."},{"key":"B42","doi-asserted-by":"publisher","first-page":"374","DOI":"10.5694\/mja2.50781","article-title":"Gut microbiota-derived trimethylamine N-oxide is associated with poor prognosis in patients with heart failure","volume":"213","author":"Li","year":"2020","journal-title":"Med J Aust."},{"key":"B43","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1093\/eurheartj\/ehw582","article-title":"Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors","volume":"38","author":"Li","year":"2017","journal-title":"Eur Heart J."},{"key":"B44","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ijcard.2017.11.071","article-title":"A potential relationship between gut microbes and atrial fibrillation: trimethylamine N-oxide, a gut microbe-derived metabolite, facilitates the progression of atrial fibrillation","volume":"255","author":"Yu","year":"2018","journal-title":"Int J Cardiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.amjms.2019.09.002","article-title":"Gut microbial metabolite trimethylamine N-oxide is related to thrombus formation in atrial fibrillation patients","volume":"358","author":"Gong","year":"2019","journal-title":"Am J Med Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s40200-021-00819-x","article-title":"Targeting TMAO and its metabolic pathway for cardiovascular diseases treatment","volume":"20","author":"Hoseini-Tavassol","year":"2021","journal-title":"J Diabetes Metab Disord"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1161\/ATVBAHA.118.311233","article-title":"Impact of gut microbiota and diet on the development of atherosclerosis in apoe(-\/-) mice","volume":"38","author":"Lindskog Jonsson","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/MBC.0000000000000838","article-title":"A bacterial metabolite, trimethylamine N-oxide, disrupts the hemostasis balance in human primary endothelial cells but no coagulopathy in mice","volume":"30","author":"Subramaniam","year":"2019","journal-title":"Blood Coagul Fibrinolysis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1152\/physiolgenomics.00089.2016","article-title":"Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41","volume":"48","author":"Natarajan","year":"2016","journal-title":"Physiol Genomics."},{"key":"B50","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/mi.2014.44","article-title":"Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR\u2013S6K pathway","volume":"8","author":"Park","year":"2015","journal-title":"Mucosal Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/sj.bjp.0705682","article-title":"Regulation of microglial inflammatory response by sodium butyrate and short-chain fatty acids","volume":"141","author":"Huuskonen","year":"2004","journal-title":"Br J Pharmacol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/s41564-018-0272-x","article-title":"Interactions between Roseburia intestinalis and diet modulate atherogenesis in a murine model","volume":"3","author":"Kasahara","year":"2018","journal-title":"Nat Microbiol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12864-021-07944-0","article-title":"Altered synthesis of genes associated with short-chain fatty acids in the gut of patients with atrial fibrillation","volume":"22","author":"Zhang","year":"2021","journal-title":"BMC Genomics."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e02298","DOI":"10.1128\/mBio.02298-19","article-title":"The microbiota promotes arterial thrombosis in low-density lipoprotein receptor-deficient mice","volume":"10","author":"Kiouptsi","year":"2019","journal-title":"mBio."},{"key":"B55","doi-asserted-by":"publisher","first-page":"101493","DOI":"10.1016\/j.beem.2021.101493","article-title":"Gut microbiome and bile acids in obesity-related diseases","volume":"35","author":"Li","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metabol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-019-0689-3","article-title":"Systematic assessment of secondary bile acid metabolism in gut microbes reveals distinct metabolic capabilities in inflammatory bowel disease","volume":"7","author":"Heinken","year":"2019","journal-title":"Microbiome."},{"key":"B57","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev-nutr-082018-124344","article-title":"Bile acids as metabolic regulators and nutrient sensors","volume":"39","author":"Chiang","year":"2019","journal-title":"Annu Rev Nutr."},{"key":"B58","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/nrendo.2014.60","article-title":"Beyond intestinal soap\u2013bile acids in metabolic control","volume":"10","author":"Kuipers","year":"2014","journal-title":"Nat Rev Endocrinol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.cmet.2011.11.006","article-title":"TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading","volume":"14","author":"Pols","year":"2011","journal-title":"Cell Metabol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.immuni.2016.09.008","article-title":"Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome","volume":"45","author":"Guo","year":"2016","journal-title":"Immunity."},{"key":"B61","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s10840-019-00540-z","article-title":"Circulating primary bile acid is correlated with structural remodeling in atrial fibrillation","volume":"57","author":"Wang","year":"2020","journal-title":"J Interv Card Electrophysiol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"e0142610","DOI":"10.1371\/journal.pone.0142610","article-title":"Metabolomics and incidence of atrial fibrillation in african americans: the atherosclerosis risk in communities (ARIC) study","volume":"10","author":"Alonso","year":"2015","journal-title":"PloS ONE."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1016\/j.amjcard.2019.03.017","article-title":"Serum metabolomics and incidence of atrial fibrillation (from the Atherosclerosis Risk in Communities Study)","volume":"123","author":"Alonso","year":"2019","journal-title":"Am J Cardiol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1136\/heartjnl-2013-304163","article-title":"Bile acids induce arrhythmias in human atrial myocardium\u2013implications for altered serum bile acid composition in patients with atrial fibrillation","volume":"99","author":"Rainer P","year":"2013","journal-title":"Heart (British Cardiac Society)."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1111\/j.1476-5381.2012.02117.x","article-title":"Regulation of apoptosis in HL-1 cardiomyocytes by phosphorylation of the receptor tyrosine kinase EphA2 and protection by lithocholic acid","volume":"167","author":"Jehle","year":"2012","journal-title":"Br J Pharmacol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1001\/jama.2019.0692","article-title":"Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Mark","year":"2019","journal-title":"JAMA."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/j.jacc.2017.08.041","article-title":"Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: the CAMERA-MRI study","volume":"70","author":"Prabhu","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"e008643","DOI":"10.1161\/JAHA.118.008643","article-title":"Effectiveness and safety of apixaban, dabigatran, and rivaroxaban versus warfarin in frail patients with nonvalvular atrial fibrillation","volume":"7","author":"Martinez","year":"2018","journal-title":"J Am Heart Assoc."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2891-12-138","article-title":"Hypocaloric diet supplemented with probiotic cheese improves body mass index and blood pressure indices of obese hypertensive patients-a randomized double-blind placebo-controlled pilot study","volume":"12","author":"Sharafedtinov","year":"2013","journal-title":"Nutr J."},{"key":"B70","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1016\/j.dsx.2018.07.016","article-title":"Probiotic and synbiotic supplementation could improve metabolic syndrome in prediabetic adults: a randomized controlled trial","volume":"13","author":"Kassaian","year":"2019","journal-title":"Diabetes Metabol Syndr."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.948755\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T05:54:03Z","timestamp":1656654843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.948755\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":70,"alternative-id":["10.3389\/fcvm.2022.948755"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.948755","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,1]]},"article-number":"948755"}}